Bristol-Myers (BMY) Completes ZymoGenetics Acquisition
Bristol-Myers Squibb Company (NYSE: BMY) announces that they have completed the acquisition of ZymoGenetics, Inc. (Nasdaq: ZGEN).
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Delphi Automotive (DLPH) in Talks with FCI to Buy Motorized Vehicles Unit
- Goldman Sachs (GS) to Announce $40B Clean Energy Investment -Reuters
- General Electric (GE) Makes $300M Investment in Large Brazilian Conglomerate
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
ZymoGenetics/Bristol-Myers SquibbSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
